Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cell

• Publication date

  2012-06-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cell.2012.04.026PMID 22682249PMCID PMC3688046
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of cancer cell metabolism

  2011cited by this paper
• Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect

  2011cited by this paper
• Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression.

  2011influential reference
• Keeping p53 in check: a high-stakes balancing act.

  2010cited by this paper
• Mouse models of p53 functions.

  2010cited by this paper
• Acetylation of Metabolic Enzymes Coordinates Carbon Source Utilization and Metabolic Flux

  2010cited by this paper
• Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells.

  2010cited by this paper
• The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein.

  2010cited by this paper
• Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species

  2010influential reference
• Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function

  2010influential reference
• Regulation of Cellular Metabolism by Protein Lysine Acetylation

  2010cited by this paper
• p53 regulation of metabolic pathways.

  2010cited by this paper
• Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis

  2009cited by this paper
• Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

  2009cited by this paper
• p53 polymorphisms: cancer implications

  2009cited by this paper
• Modes of p53 regulation.

  2009cited by this paper
• Blinded by the Light: The Growing Complexity of p53.

  2009cited by this paper
• hMOF, a KAT(8) with many lives.

  2009cited by this paper
• Two mammalian MOF complexes regulate transcription activation by distinct mechanisms.

  2009cited by this paper
• Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions

  2009cited by this paper
• In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute

  2008cited by this paper
• PUMA, a potent killer with or without p53

  2008cited by this paper
• p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation

  2008cited by this paper
• Acetylation is indispensable for p53 activation.

  2008influential reference
• Selection against PUMA Gene Expression in Myc-Driven B-Cell Lymphomagenesis

  2008cited by this paper
• 18F-FDG PET and PET/CT in fever of unknown origin.

  2007cited by this paper
• DNA damage-induced cellular senescence is sufficient to suppress tumorigenesis: a mouse model

  2007cited by this paper
• Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53‐dependent cellular senescence

  2007cited by this paper
• Acetylation of the p53 DNA-binding domain regulates apoptosis induction.

  2006cited by this paper
• TIGAR, a p53-inducible regulator of glycolysis and apoptosis.

  2006cited by this paper
• Substrate and functional diversity of lysine acetylation revealed by a proteomics survey.

  2006cited by this paper
• Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence

  2006cited by this paper
• Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation

  2006cited by this paper
• Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis.

  2006cited by this paper
• Functional Analysis of the Roles of Posttranslational Modifications at the p53 C Terminus in Regulating p53 Stability and Activity

  2005cited by this paper
• The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation.

  2005cited by this paper
• Lack of expression of the liver-type glutaminase (LGA) mRNA in human malignant gliomas.

  2005cited by this paper
• Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer

  2005cited by this paper
• Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice

  2004cited by this paper
• The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression

  2004cited by this paper
• Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways

  2003cited by this paper
• Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation.

  2003cited by this paper
• Glucose transporters: expression, regulation and cancer.

  2002cited by this paper
• hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

  2001cited by this paper
• Negative Control of p53 by Sir2 Promotes Cell Survival under Stress

  2001cited by this paper
• Negative control of p53 by Sir2alpha promotes cell survival under stress.

  2001cited by this paper
• Deacetylation of p53 modulates its effect on cell growth and apoptosis

  2000cited by this paper
• Surfing the p53 network

  2000cited by this paper
• Requirement for p53 and p21 to sustain G2 arrest after DNA damage.

  1998cited by this paper
• Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

  1997cited by this paper
• A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

  1995cited by this paper
• Tumor spectrum analysis in p53-mutant mice.

  1994cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• The pentose cycle and insulin release in mouse pancreatic islets.

  1972cited by this paper
• [Origin of cancer cells].

  1956cited by this paper
• On the origin of cancer cells.

  1956cited by this paper

• SLC2A3-Mediated Lactate Metabolism Promotes Lung Cancer Bone Metastasis by Modulating P53 Lactylation and Immune Evasion.

  2026cites this paper
• Programmed cell death network in cancer drug resistance: A framework for therapeutic intervention.

  2026cites this paper
• Oncogenic chromodomain mutations allosterically impair TIP60 acetyltransfearse function preventing activation of DNA repair genes under genotoxic stress

  2026cites this paper
• Bioinformatics analysis of the expression of TRIM31 mRNA and protein in pan-cancer tissues and their prognostic relevance

  2025cites this paper
• Mutation of p53 Acetylation Protects Against Angiotensin-II-Induced Cardiac Dysfunction and Fibrosis

  2025cites this paper
• Hereditary cancer syndromes linked to oxidative phosphorylation insufficiency

  2025cites this paper
• Pharmacological rescue of mutant p53 triggers spontaneous tumor regression via immune responses

  2025cites this paper
• Acalypha indica Linn. leaf methanolic extract inhibits A549 adenocarcinoma cell proliferation via Bax/Bcl2 mediated intrinsic apoptosis pathway

  2025cites this paper
• NDRG1 and its family members: More than just metastasis suppressor proteins and targets of thiosemicarbazones

  2025cites this paper
• Pan-cancer multi-omic model of LINE-1 activity reveals locus heterogeneity of retrotransposition efficiency

  2025cites this paper
• Ferroptosis in Cancer and Inflammatory Diseases: Mechanisms and Therapeutic Implications

  2025cites this paper
• Lipid nanoparticle-assisted mRNA therapy for cancer treatment

  2025cites this paper
• Targeting ferroptosis in cancer therapy: Mechanisms, strategies, and clinical applications

  2025cites this paper
• The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis

  2025cites this paper
• Engineering precision zebrafish alleles of human disease

  2025cites this paper
• Polyherbal Formulation as a Therapeutic Strategy for Lung Cancer: Phytochemical Profiling, Molecular Docking, and Pharmacological Evaluation

  2025cites this paper
• Knowledge mapping of ferroptosis in sarcoma: a bibliometric and bioinformatics analysis (2012–2023)

  2025cites this paper
• The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy

  2025cites this paper
• Bypassing the guardian: regulated cell death pathways in p53-mutant cancers

  2025cites this paper
• TP53‐Mutated Acute Myeloid Leukemia: Unanswered Questions

  2025cites this paper
• Stem Cells in Cancer: From Mechanisms to Therapeutic Strategies

  2025cites this paper
• p53 Drives Lung Cancer Regression through a TSC2/TFEB-dependent Senescence Program

  2025cites this paper
• FBR2 modulates ferroptosis via the SIRT3/p53 pathway to ameliorate pulmonary fibrosis

  2025cites this paper
• Silencing ribosome biogenesis regulator 1 homolog (RRS1) inhibits angiogenesis and cisplatin resistance of lung cancer cells by activating ferroptosis mediated by p53 pathway.

  2025cites this paper
• The formin-like regulates innate immunity and antibacterial immune responses in Scylla paramamosain

  2025cites this paper
• The key vulnerabilities and therapeutic opportunities in the USP7-p53/MDM2 axis in cancer.

  2025cites this paper
• Oxidative Stress Disrupts Gill Function in Eriocheir sinensis: Consequences for Ion Transport, Apoptosis, and Autophagy

  2025cites this paper
• Natsudaidain alleviates acute lung injury through the PI3K/Akt and P53 signaling pathways by inhibiting MLE-12 apoptosis: a network pharmacology study and experimental validation.

  2025cites this paper
• The Molecular Interplay Between p53-Mediated Ferroptosis and Non-Coding RNAs in Cancer

  2025cites this paper
• Designer polyQ fusion proteins sequester USP7/HDM2 for modulating P53 functionality

  2025cites this paper
• SLC7A11 Inhibitors Represent a Promising Therapeutic Target by Facilitating the Induction of Ferroptosis in Breast Cancer

  2025cites this paper
• Mis-splicing drives loss of function of p53E224D point mutation

  2025cites this paper
• Palladium(II) oxime complex: synthesis, structural characterization, and antiproliferative effects on HepG-2 cells via the P53/Caspase-3 pathway

  2025cites this paper
• Uncovering the mechanism of resveratrol in the treatment of asthma: a network pharmacology approach with molecular docking and experimental validation

  2025cites this paper
• The TP53 tumor suppressor gene: From molecular biology to clinical investigations

  2025cites this paper
• Ultrasound-targeted microbubble destruction mediated upregulation of CNN1 induces ferroptosis in colorectal cancer cells by regulating p53-related SLC7A11 expression.

  2025cites this paper
• Metabolic adaptations in cancer progression.

  2025cites this paper
• Advances of mRNA vaccines in genitourinary cancers.

  2025cites this paper
• Gut microbes and their metabolites in relation to the classic tumor suppressor gene P53: a novel narrative

  2025cites this paper
• Specific TP53 mutations impair the recruitment of 53BP1 to DNA double-strand breaks underlying the mechanism of radioresistance

  2025cites this paper
• Exercise alters transcriptional profiles of senescence and gut barrier integrity in intestinal crypts of aging mice

  2025cites this paper
• Structural dynamics of the wild-type p53 DNA-binding domain and hotspot mutants reveal oncogenic conformational shifts.

  2025cites this paper
• p21, ccng1, foxo3b, and fbxw7 contribute to p53-dependent cell cycle arrest

  2025cites this paper
• p53-regulated non-apoptotic cell death pathways and their relevance in cancer and other diseases

  2025cites this paper
• Natural Agents Modulating Ferroptosis in Cancer: Molecular Pathways and Therapeutic Perspectives

  2025cites this paper
• Complex p53 dynamics regulated by miR-125b in cellular responses to reactive oxidative stress and DNA damage

  2024cites this paper
• Betanin inspired zinc oxide nanoparticles: The potential antioxidant and anticancer activity against human lung cancer cell line (A549).

  2024cites this paper
• Ferroptosis: when metabolism meets cell death.

  2024cites this paper
• Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope

  2024cites this paper
• Breathing new insights into the role of mutant p53 in lung cancer

  2024cites this paper
• Multiple roles of p53 in cancer development: Regulation of tumor microenvironment, m6A modification and diverse cell death mechanisms

  2024cites this paper
• Vulnerability of Antioxidant Drug Therapies on Targeting the Nrf2-Trp53-Jdp2 Axis in Controlling Tumorigenesis

  2024cites this paper
• Npac Regulates Pre-mRNA Splicing in Mouse Embryonic Stem Cells

  2024cites this paper
• Antisense-mediated splicing correction as a therapeutic approach for p53 K120R mutation

  2024cites this paper
• Chronic obesity does not alter cancer incidence in Trp53R270H/+ mice

  2024cites this paper
• Effects of uric acid on oxidative stress in vascular smooth muscle cells

  2024cites this paper
• PHLDA2 is critical for p53-mediated ferroptosis and tumor suppression

  2024cites this paper
• xCT as a Predictor for Survival in a Population‐Based Cohort of Head and Neck Squamous Cell Carcinoma

  2024cites this paper
• Graphene oxide in low concentrations can change mitochondrial potential, autophagy, and apoptosis paths in two strains of invertebrates with different life strategies.

  2024cites this paper
• Anti-cancer activity of Brucine loaded Cu(OH)2/ZnO Nanoparticles Against Chronic Myeloid Leukemia Cell Line (K562) via apoptotic signaling Pathway

  2024cites this paper
• COPPER NANOPARTICLES AFFECTING APOPTOSIS RELATED GENE EXPRESSION AND THE PROTECTIVE EFFECT OF ALPHA-LIPOIC ACID IN ADULT MALE ALBINO RATS: A CHRONIC STUDY

  2024cites this paper
• Oncogenic HJURP enhancer promotes the aggressive behavior of triple-negative breast cancer in association with p53/E2F1/FOXM1-axis.

  2024cites this paper
• Lomitapide repurposing for treatment of malignancies: A promising direction

  2024cites this paper
• An update on the role of ferroptosis in the pathogenesis of osteoporosis

  2024cites this paper
• Ferroptosis: A double-edged sword

  2024cites this paper
• Harnessing the power of Neobacillus niacini AUMC-B524 for silver oxide nanoparticle synthesis: optimization, characterization, and bioactivity exploration

  2024cites this paper
• Comprehensive analysis of the potential pathogenesis of COVID-19 infection and liver cancer

  2024cites this paper
• Diphthamide deficiency promotes association of eEF2 with p53 to induce p21 expression and neural crest defects

  2024cites this paper
• XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53–p21 and p27 pathways

  2024cites this paper
• The TP53-activated E3 ligase RNF144B is a tumour suppressor that prevents genomic instability

  2024cites this paper
• The p53 protein - not only the guardian of the genome.

  2024cites this paper
• Pro-ferroptotic signaling promotes arterial aging via vascular smooth muscle cell senescence

  2024cites this paper
• Harnessing ferroptosis for enhanced sarcoma treatment: mechanisms, progress and prospects

  2024cites this paper
• Understanding the complexity of p53 in a new era of tumor suppression.

  2024cites this paper
• Mouse models to investigate in situ cell fate decisions induced by p53

  2024cites this paper
• Q‐switched 1064 nm Nd: YAG laser restores skin photoageing by activating autophagy by TGFβ1 and ITGB1

  2024cites this paper
• Pioneering the future of cancer therapy: Deciphering the p53-ferroptosis nexus for precision medicine.

  2024cites this paper
• Immunohistochemical expression of p53, beta-catenin, and PD-L1 in colorectal carcinoma with respect to grade and stage-an observational study in a tertiary care center

  2024cites this paper
• Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy

  2024cites this paper
• KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis

  2024cites this paper
• Decoding p53 tumor suppression: a crosstalk between genomic stability and epigenetic control?

  2024cites this paper
• The CDK4/6 Inhibitor Palbociclib Induces Cell Senescence of High-grade Serous Ovarian Cancer Through Acetylation of p53

  2024cites this paper
• p53: A tale of complexity and context.

  2024cites this paper
• Oxidative Stress and Chronic Myeloid Leukemia: A Balance between ROS-Mediated Pro- and Anti-Apoptotic Effects of Tyrosine Kinase Inhibitors

  2024cites this paper
• HOPS/TMUB1 Enhances Apoptosis in TP53 Mutation-Independent Setting in Human Cancers

  2024cites this paper
• Elucidating the chain of command: our current understanding of critical target genes for p53-mediated tumor suppression

  2024cites this paper
• Investigating the anticancer effects of chitosan-NLC-folate nanohybrid loaded with auraptene on A2780 ovarian cancer cells

  2024cites this paper
• Ferroptosis: Molecular Perspective, Cellular Influence, Cancer Manifestation And Therapeutic Potentials

  2024cites this paper
• Drug-Induced p53 Activation Limits Pancreatic Cancer Initiation

  2024cites this paper
• Suppression of TREX1 deficiency-induced cellular senescence and interferonopathies by inhibition of DNA damage response

  2023cites this paper
• The crisscross between p53 and metabolism in cancer

  2023cites this paper
• Experimental Insights into the Interplay between Histone Modifiers and p53 in Regulating Gene Expression

  2023cites this paper
• mRNA-based cancer therapeutics

  2023cites this paper
• Emerging role of RNA acetylation modification ac4C in diseases:current advences and future challenges.

  2023cites this paper
• SCARNA10 regulates p53 acetylation-dependent transcriptional activity.

  2023cites this paper
• Somatic-to-primordial germ cell-like transformation is critical in tumor initiation of mouse breast tumor 4T1 cells.

  2023cites this paper
• Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genes

  2023cites this paper
• Mechanism-guided quantification of LINE-1 reveals p53 regulation of both retrotransposition and transcription

  2023cites this paper
• Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy

  2023cites this paper
• Recent Advances in Site-Specific Lipid Nanoparticles for mRNA Delivery

  2023cites this paper